Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COPD Bronchitis”

248 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 248 results

Post-approval studies (Phase 4)Study completedNCT03073798
What this trial is testing

The Effectiveness of Roflumilast in Improving Mucociliary Clearance in Patients With COPD and Chronic Bronchitis

Who this might be right for
COPDChronic BronchitisEmphysema
Johns Hopkins University 12
Not applicableStudy completedNCT02130986
What this trial is testing

Procalcitonin Antibiotic Consensus Trial (ProACT)

Who this might be right for
Lower Respiratory Tract Infection (LRTI)
University of Pittsburgh 1,664
Large-scale testing (Phase 3)Study completedNCT01437397
What this trial is testing

Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 1,692
Testing effectiveness (Phase 2)Study completedNCT01049360
What this trial is testing

Efficacy and Safety Study of Two Fixed-dose Combinations of Aclidinium Bromide With Formoterol Fumarate Compared With Aclidinium Bromide, Formoterol Fumarate and Placebo

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 128
Post-approval studies (Phase 4)Study completedNCT00424528
What this trial is testing

Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary DiseaseBronchitisEmphysema
Sumitomo Pharma America, Inc. 235
Not applicableUnknownNCT03631472
What this trial is testing

Gala Early Feasibility Study of RheOx

Who this might be right for
Chronic BronchitisCopd Bronchitis
Gala Therapeutics, Inc. 21
Not applicableStudy completedNCT01949727
What this trial is testing

Examining Vascular Outcomes in COPD Inpatients (AIM 1) Examining Early Rehabilitation on Discharged COPD Patients (AIM 2)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
University of Alberta 111
Not applicableNot Yet RecruitingNCT06921278
What this trial is testing

Development of the Drug and Alcohol Respiratory Health Test

Who this might be right for
Respiratory DiseaseSubstance-Related DisordersCOPD+6 more
King's College London 260
Not applicableNot Yet RecruitingNCT06646991
What this trial is testing

Comparison of Several Oxygenation Targets With Different Oxygen Interfaces - Impact on Oxygen Flow Rates

Who this might be right for
Oxygen ToxicityCOPD BronchitisRespiratory Failure
Laval University 20
Post-approval studies (Phase 4)Study completedNCT01363531
What this trial is testing

Clinical Trial for the Assessment of Delayed Antibiotic Treatment Strategies

Who this might be right for
PharyngitisAcute TonsillitisRhinosinusitis+2 more
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 405
Post-approval studies (Phase 4)Study completedNCT00202176
What this trial is testing

Effects of Bronchodilators in Mild Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Queen's University 32
Large-scale testing (Phase 3)Study completedNCT00891462
What this trial is testing

Efficacy and Safety of Aclidinium Bromide for Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-33)

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 561
Testing effectiveness (Phase 2)Study completedNCT00373932
What this trial is testing

Real-Time Support for Exercise Persistence in COPD

Who this might be right for
Pulmonary Disease, Chronic ObstructiveCOPDEmphysema+1 more
University of Washington 17
Testing effectiveness (Phase 2)Study completedNCT00992680
What this trial is testing

A Pilot Study to Evaluate the ROX Anastomotic Coupler System in Patients With Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease
ROX Medical, Inc. 49
Testing effectiveness (Phase 2)Study completedNCT01078623
What this trial is testing

Efficacy and Safety of Two Fixed Dose Combinations of Aclidinium Bromide With Formoterol Fumarate

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 176
Not applicableEnrolling By InvitationNCT05952999
What this trial is testing

Analysis of the Virtual Acute Care at Home Experience

Who this might be right for
ConditionsInfectionsHeart Failure+6 more
OSF Healthcare System 9,654
Testing effectiveness (Phase 2)UnknownNCT05507242
What this trial is testing

Effects of Blocking TSLP on Airway Inflammation and the Epithelial Immune-response to Exacerbation Triggers in Patients With COPD

Who this might be right for
COPDCOPD ExacerbationCOPD Bronchitis+2 more
Asger Sverrild 80
Testing effectiveness (Phase 2)Study completedNCT02951312
What this trial is testing

Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [ie, Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered With an Electronic eFlow Nebulizer System in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Sunovion Respiratory Development Inc. 12
Not applicableStudy completedNCT03957577
What this trial is testing

Etiology of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) in Japan

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 70
Post-approval studies (Phase 4)Ended earlyNCT02416102
What this trial is testing

Effect of Losartan on Airway Mucociliary Dysfunction in Patients With COPD and Chronic Bronchitis

Who this might be right for
COPDChronic Bronchitis
University of Miami 31
Next Page